Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Ositive highlevel results from a planned interim analysis of the DESTINYBreast Phase III trial showed Enhertu trastuzumab deruxtecan demonstrated a highly statistically significant and clinically meaningful improvement in invasive diseasefree surviva...
Pier Health a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical innovations to Greater China and Theranica a prescribed digital therapeutics company
FullLife Technologies a fullyintegrated global radiotherapeutics company today announced the completion of US million financing comprised of close to US million Series C equity and US million debt financing
Genmab ASand Merus NVannounced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus a clinicalstage biotechnology company with its latestage breakthrough therapy asset petosemta...
Health Hope Pharma Limited HHP today announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences Inc Gilead for encequidar a firstinclass Pglycoprotein Pgp inhibitor in the field of virology
SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system today announced that the board of directors resolved to initiate
AIM ImmunoTech Inctoday announced that the Japan Patent Office has issued a patent covering the Companys proprietary use of Ampligen Rintatolimod in combination with checkpoint inhibitors antiPD or antiPDL antibodies for the treatment of cancer
Respira Therapeutics Inc a Samsara BioCapital portfolio company today announced that it has entered into an agreement with Gossamer Bio Inc GossamerNasdaq GOSS granting Gossamer an option to acquire the Company
Crinetics Pharmaceuticals Inctoday announced that the US Food and Drug Administration FDA approved PALSONIFY paltusotine for the firstline treatment of adults with acromegaly who had an inadequate response to surgery andor for whom surgery is not an...
WuXi Biologics a leading global Contract Research Development and Manufacturing Organization CRDMO today announced the launch of TrueSite TITM an industryleading targeted integration